Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of VCAP-AMP-VECP vs. Biweekly CHOP in Aggressive Adult T-cell Leukemia-lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.

NCT00145002 is registered in ClinicalTrials.gov with Japan Clinical Oncology Group as lead sponsor.

NCT NCT00145002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00145002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of VCAP-AMP-VECP vs. Biweekly CHOP in Aggressive Adult T-cell Leukemia-lymphoma (ATLL): Japan Clinical Oncology Group Study, JCOG9801.
Lead sponsor
Japan Clinical Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
August 31, 1998
Completion date
December 31, 2004
Enrollment
130
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult t-cell leukemia, lymphoma